IL7 and hematopoietic and lymphoid system neoplasm: In fact, lack of IL-7 is associated with severe immunodeficiency and presence of IL-7 in blood cancer patients is an indication of better prognosis which is associated with activating immune effector cells in tumor hosts [51–53].